Delivery Order SPE2DB22D3004-SPE2DB25FQB69
Award Date
3/27/25
Potential Completion Date
4/17/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 120 units of the prescription drug BOSULIF 100 MG TABLET. The firm fixed price contract has a ceiling value of $5,704.45 and an ultimate completion date of June 27, 2025. The award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of Bosulif 400 mg tablets, a specialty medication, at a firm fixed price of $21,910.86. The award is not associated with a set-aside program and has an ultimate completion date of September 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,631.26 firm fixed-price contract is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bosulif 400 mg tablets. The $23,631.26 firm-fixed-price contract has a completion date of May 27, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BOSULIF 100 MG TABLET 120S, a prescription medication, with a firm fixed price and a ceiling value of $5,704.45. The contract has an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,815.63 contract is for the delivery of Bosulif 400 mg tablets, a prescription medication. The award has a performance period ending on June 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which allows the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The firm fixed price contract, valued at $9,888.50, is for the delivery of 4563956004 - BOSULIF 500 MG TABLET 30S. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $9,982.56 order is for the delivery of BOSULIF 100 MG TABLET 120S, a brand name pharmaceutical product, with a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,523.71 firm fixed-price delivery order is for the supply of 120 tablets of the medication Bosulif 100 mg. The contract has an ultimate completion date of April 29, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $5,523.71 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 120 tablets of the drug Bosulif 100 mg. This contract has a completion date of February 7, 2025 and was awarded on January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a range of...